Local endostatin treatment of gliomas administered by microencapsulated producer cells

Nature Biotechnology

Volumn 19, Issue 1, 2001, Pages 29-34

  Read, Tracy Ann ^a   Sorensen, Dag R ^b   Mahesparan, Rupavathana ^a   Enger, Per Ø ^a   Timpl, Rupert ^c   Olsen, Bjørn R ^d   Hjelstuen, Mari H B ^e   Haraldseth, Olav ^f   Bjerkvig, Rolf ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e SINTEF   (Norway)

^f NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Alginate; Brain tumors; Encapsulation; Producer cells

Indexed keywords

ALGINIC ACID; ANGIOGENESIS INHIBITOR; DIVALENT CATION; ENDOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TUMOR; CELL HYPOXIA; CELL SURVIVAL; CONTROLLED STUDY; DRUG CAPSULE; DRUG RELEASE; FEMALE; GENETIC ENGINEERING; GENETIC TRANSFECTION; GLIOMA; IN VITRO STUDY; IN VIVO STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; TUMOR CELL LINE; TUMOR VASCULARIZATION;

ALGINATES; ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; BRAIN NEOPLASMS; CAPSULES; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; CELL TRANSPLANTATION; COLLAGEN; ENDOSTATINS; GLIOMA; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MAGNETIC RESONANCE IMAGING; PEPTIDE FRAGMENTS; RATS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0035174207     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/83471     Document Type: Article

References (39)

1. Structural development in gliomas
2. Angiogenesis in malignant gliomas
3. Suppression of angiogenesis and tumor growth by the inhibitor K1 - 5 Generated by plasmin-mediated proteolysis
4. Thrombospondin acts via integrin-associated protein to activate the platelet integrin alphallbbeta3
5. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
6. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
7. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
8. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
9. Glioblastoma
10. Developing new methods for the treatment of malignant brain tumours: Local delivery of anti-neoplastic agents using biodegradable polymers
11. Treatment of diseases of the central nervous system using encapsulated cells
12. Immunotherapy with monoclonal antibodies directed against the immunosuppressive domain of p15E inhibits tumour growth
13. Microencapsulated islets as bioartificial endocrine pancreas
14. Alginate as immobilization material: I. Correlation between chemical and physical properties of alginate gel beads
15. Alginate as immobilization material: III. Diffusional properties
16. Cells encapsulated in alginate: A potential system for delivery of recombinant proteins to malignant brain tumours
17. Transport and elimination of recombinant human NGF during long-term delivery to the brain
18. Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain
19. Alginate encapsulated producer cells: A potential new approach to the treatment of malignant brain tumours
20. Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsules
21. Interstitial fluid pressure in intracranial tumours in patients and in rodents
22. Relationship of perfusion to edema in the 9L glioma
23. Endostatin induces endothelial cell apoptosis
24. Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding
25. Endostatin inhibits VEGF-induced endothelial ceil migration and tumour growth independently of zinc binding
26. Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia
27. Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas
28. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
29. Cell-extracellular matrix interacttion in glioma invasion
30. Effect of local anti-VEGF antibody treatment on tumor microvessel permeability
31. Neoplastic transformation of fetal rat brain cells in culture after exposure to ethylnitrosourea in vivo
32. A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots
33. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin
34. Characteristic protein fractions of cerebrospinal fluid disc electrophoretic analysis
35. acZ-neoR transfected glioma cells in syngeneic rats: Growth pattern and characterization of the host immune response against cells transplanted inside and outside the CNS
36. MT CL-HPR: A new enhanced chemiluminescent substrate for the development of horseradish peroxidase label in western blotting applications
37. Genotypes and phenotypes of ten inbred strains of BD-rats
38. Pimonidazole: A novel hypoxia marker for complementary study of tumour hypoxia and cell proliferation in cervical carcinoma
39. Extracellular matrix-induced cell migration from glioblastoma specimens in vitro